Literature DB >> 25953442

Screening the molecular targets of ovarian cancer based on bioinformatics analysis.

Lei Du1, Xiaolei Qian, Chenyang Dai, Lihua Wang, Ding Huang, Shuying Wang, Xiaowei Shen.   

Abstract

AIMS AND
BACKGROUND: Ovarian cancer (OC) is the most lethal gynecologic malignancy. This study aims to explore the molecular mechanisms of OC and identify potential molecular targets for OC treatment. METHODS AND STUDY
DESIGN: Microarray gene expression data (GSE14407) including 12 normal ovarian surface epithelia samples and 12 OC epithelia samples were downloaded from Gene Expression Omnibus database. Differentially expressed genes (DEGs) between 2 kinds of ovarian tissue were identified by using limma package in R language (|log2 fold change| gt;1 and false discovery rate [FDR] lt;0.05). Protein-protein interactions (PPIs) and known OC-related genes were screened from COXPRESdb and GenBank database, respectively. Furthermore, PPI network of top 10 upregulated DEGs and top 10 downregulated DEGs was constructed and visualized through Cytoscape software. Finally, for the genes involved in PPI network, functional enrichment analysis was performed by using DAVID (FDR lt;0.05).
RESULTS: In total, 1136 DEGs were identified, including 544 downregulated and 592 upregulated DEGs. Then, PPI network was constructed, and DEGs CDKN2A, MUC1, OGN, ZIC1, SOX17, and TFAP2A interacted with known OC-related genes CDK4, EGFR/JUN, SRC, CLI1, CTNNB1, and TP53, respectively. Moreover, functions about oxygen transport and embryonic development were enriched by the genes involved in the network of downregulated DEGs.
CONCLUSIONS: We propose that 4 DEGs (OGN, ZIC1, SOX17, and TFAP2A) and 2 functions (oxygen transport and embryonic development) might play a role in the development of OC. These 4 DEGs and known OC-related genes might serve as therapeutic targets for OC. Further studies are required to validate these predictions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25953442     DOI: 10.5301/tj.5000319

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  5 in total

1.  ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.

Authors:  Wei Han; Fang Cao; Xiao-Jiao Gao; Hua-Bing Wang; Fang Chen; Si-Jian Cai; Cong Zhang; Yong-Wei Hu; Jun Ma; Xing Gu; Hou-Zhong Ding
Journal:  Int J Oncol       Date:  2018-06-21       Impact factor: 5.650

2.  High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma.

Authors:  Chun-Tao Shi; Jun Ma; Qi-Feng Shi; Ye Zhang; Hao-Nan Wang
Journal:  J Breast Cancer       Date:  2019-04-19       Impact factor: 3.588

3.  Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.

Authors:  Di Meng; Tongjun Liu; Feng Ma; Mingguo Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

4.  Prognostic and clinicopathological value of ZIC1 in patients with cervical squamous cell carcinoma.

Authors:  Xing Gu; Xue-Ke Guo; Bi-Hui Chen; Xiao-Jiao Gao; Fang Chen; Qin Liu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 5.  Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.

Authors:  Vu Hong Loan Nguyen; Rebecca Hough; Stefanie Bernaudo; Chun Peng
Journal:  J Ovarian Res       Date:  2019-12-11       Impact factor: 4.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.